HK Stock Market Move | YICHEN IND (01596) rose more than 76% after Yingxi expected annual consolidated net profit of approximately RMB333 million. The company benefited from increased railway investments.
Wing Sun Industrial (01596) surged more than 76% after the profit announcement, as of the time of writing, it rose by 60.71% to 0.9 Hong Kong dollars, with a turnover of 14.94 million Hong Kong dollars.
YICHEN IND (01596) surged more than 76% at one point, and as of the time of writing, it had risen by 60.71%, to 0.9 Hong Kong dollars with a trading volume of 149.412 million Hong Kong dollars.
On the news front, on March 13, YICHEN IND announced that it is expected to achieve a consolidated net profit of approximately 334 million yuan for the year ending December 31, 2025. This is a turnaround from a consolidated net loss of approximately 57.7 million yuan for the year ending December 31, 2024.
The board believes that the expected improvement in the group's financial performance is mainly due to an increase in the shipment volume of the group's railway fastening system products and a decrease in raw material procurement prices in the 2025 fiscal year. As a result, the group's revenue is expected to increase from approximately 1.091 billion yuan in the 2024 fiscal year to approximately 1.667 billion yuan in the 2025 fiscal year, an increase of approximately 576 million yuan or about 52.8%. The group's gross profit in the 2025 fiscal year is expected to increase by approximately 331 million yuan, an increase of about 130.8%.
This growth is also consistent with the continued increase in China's railway infrastructure investment. According to data released by the China National Railway Administration, in 2025, the country's completed investment in fixed railway assets reached approximately 901.5 billion yuan, an increase of approximately 6.0% compared to the previous year, with approximately 3,109 kilometers of new lines put into operation, including about 2,862 kilometers of high-speed rail.
Related Articles

CHINA LILANG (01234) releases annual performance with a shareholders' profit of 502 million yuan, a year-on-year increase of 9%.

SSY GROUP (02005): Bumetanide has been approved by the National Medical Products Administration and registered as an active pharmaceutical ingredient for use in marketed preparations.

KNOWLEDGE ATLAS (02513) releases a large model specifically designed for lobsters. Despite a 20% price increase, demand still exceeds supply.
CHINA LILANG (01234) releases annual performance with a shareholders' profit of 502 million yuan, a year-on-year increase of 9%.

SSY GROUP (02005): Bumetanide has been approved by the National Medical Products Administration and registered as an active pharmaceutical ingredient for use in marketed preparations.

KNOWLEDGE ATLAS (02513) releases a large model specifically designed for lobsters. Despite a 20% price increase, demand still exceeds supply.






